Back

Causes and prognostic implications of hospital admissions following successful heart transplantation

17 May 2025 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Optimisation of heart transplant care and management Heart Transplantation HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Marcia Presume

Hospital Santa Cruz, Lisbon (Portugal)

Photo
Doctor Rita Carvalho

Western Lisbon Hospital Centre, EPE, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
Predictors of cardiac allograft vasculopathy and dysfunction in heart transplantation: a single-center study
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
The impact of induction therapy in ECMO-HTx: early mortality and long-term outcomes
Associate Professor J. Lee (Cheongju, KR)
Abstract Slides Video
Presentation thumbnail
Idarucizumab for dabigatran reversal in cardiac transplant recipients: outcomes and blood product transfusion use.
Doctor F. Sansegundo Burgueno (La Laguna, ES)
Abstract Slides Video
Presentation thumbnail
Incidence and characteristics of rejection in heart transplant recipients: analysis of a contemporary follow-up protocol based on endomyocardial biopsy.
Doctor E. Mateu Gisbert (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Transplanting the neglected guy: hypertrophic cardiomyopathy and risk factors on the waiting list
Doctor M. Masetti (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Optimisation of heart transplant care and management

The Event

Event poster

Heart Failure 2025

17 May 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Causes and prognostic implications of hospital admissions following successful heart transplantation
thumbnail
Congress Presentation
Comparative analysis of outcomes: heart transplantation vs. left ventricular assist device therapy
thumbnail
Congress Presentation
The impact of induction therapy in ECMO-HTx: early mortality and long-term outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources